TD Cowen Sticks to Its Buy Rating for Sangamo Biosciences (SGMO)
In a report released today, Ritu Baral from TD Cowen maintained a Buy rating on Sangamo Biosciences (SGMO – Research Report). The company’s ...
Sangamo reports updated data for gene therapy candidate ST-920
Sangamo (SGMO) reported positive updated data from a Phase 1/2 study of its gene therapy candidate ST-920 in the treatment of Fabry disease. Read more here.
South County Publications1d
Trojans defeat Riverton, Athens in Sangamo, extend winning streak to 12
Auburn remained in a tie for first place in the Sangamo Conference and extended its current win streak to 12 with hard-fought wins over Riverton (58-44) and Athens (68-52) last week. The final scores ...
Sangamo reports positive Fabry disease gene therapy results
RICHMOND, Calif. - Sangamo Therapeutics, Inc. (NASDAQ: SGMO), a genomic medicine company with a market capitalization of $263 million, has announced promising updated results from its Phase 1/2 STAAR ...
Sangamo announces updated data from STAAR study
Sangamo (SGMO) announced updated data from the Phase 1/2 STAAR study evaluating isaralgagene civaparvovec, or ST-920, a wholly owned gene ...
Ford County6d
PBL girls basketball wins 53-36 over Riverton in IPC/Sangamo Shootout
The Paxton-Buckley-Loda varsity girls basketball team won 53-36 over Riverton in the Illini Prairie/Sangamo Conference Shootout on Saturday. Tanner Graham finished with 14 points and would be named ...